Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3961385 | 0.79 | TSHR (0.38) | TSHRMAPK1HSD17B10TDP1THRB | |
| SCHEMBL8210522 | 0.78 | TSHR (0.37) | TSHRMAPK1HSD17B10TDP1THRB | |
| SCHEMBL8858302 | 0.78 | — | — | |
| SCHEMBL9161010 | 0.76 | TSHR (0.40) | TSHRMAPK1HSD17B10TDP1THRB | |
| SCHEMBL31124103 | 0.76 | KDM4E (0.30) | — | |
| SCHEMBL8837708 | 0.76 | TSHR (0.36) | TSHRMAPK1HSD17B10TDP1THRB | |
| SCHEMBL1236079 | 0.74 | TSHR (0.35) | TSHRMAPK1HSD17B10TDP1THRB | |
| SCHEMBL544788 | 0.74 | TSHR (0.35) | TSHRMAPK1HSD17B10TDP1THRB | |
| SCHEMBL27361330 | 0.74 | TSHR (0.35) | TSHRMAPK1HSD17B10TDP1THRB | |
| SCHEMBL1982478 | 0.74 | TSHR (0.39) | TSHRMAPK1HSD17B10TDP1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 164 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114784346-B | Proton exchange membrane for battery, preparation method and nanofiber composite structure | 清华大学 | 2022-09-06 | — | — | CN | claimed |
| CN-114784346-A | Proton exchange membrane for battery, preparation method and nanofiber composite structure | 清华大学 | 2022-07-22 | — | — | CN | claimed |
| US-7452938-B2 | Aqueous resin composition, aqueous coating material containing the composition, coating provided by the material, and metal plate coated with the material | TOYO BOSEKI KABUSHIKI KAISHA (JP) | 2008-11-18 | — | — | US | claimed |
| JP-59081192-A | — | — | None | — | — | JP | disclosed |
| CN-122095316-A | Composition for forming resist underlayer film | — | 2026-05-26 | — | — | CN | disclosed |
| WO-2025095106-A1 | RESIST UNDERLAYER FILM FORMATION COMPOSITION | 日産化学株式会社 | 2025-05-08 | — | — | WO | disclosed |
| US-20250051352-A1 | DIARYLOXYBENZOHETERODIAZOLE COMPOUNDS DISUBSTITUTED WITH THIENOTHIOPHENE GROUPS | ENI S.P.A. (IT) | 2025-02-13 | — | — | US | disclosed |
| EP-4444723-A1 | DIARYLOXYBENZOHETERODIAZOLE COMPOUNDS DISUBSTITUTED WITH THIENOTHIOPHENE GROUPS | ENI S.p.A. (IT) | 2024-10-16 | — | — | EP | disclosed |
| CN-114746468-B | Method for producing polymer | 日产化学株式会社 | 2024-09-13 | — | — | CN | disclosed |
| CN-118284614-A | Diaryloxybenzobisoxazole compounds disubstituted with thienothiophene groups | 埃尼股份公司 | 2024-07-02 | — | — | CN | disclosed |
| US-20230321943-A1 | Multilayered Container And Method For Producing Same | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2023-10-12 | — | — | US | disclosed |
| EP-1120223-A1 | Coinjection stretch blow molded container | KURARAY CO., LTD. (JP) | 2001-08-01 | — | — | EP | disclosed |
| US-6254669-B1 | Bleed reduction agents for ink printing inks | ZENECA LIMITED (GB) | 2001-07-03 | — | — | US | disclosed |
| EP-0949056-A2 | Coinjection stretch blow molded container | KURARAY CO., LTD. (JP) | 1999-10-13 | — | — | EP | disclosed |
| US-5686553-A | TEREPHTHALIC ACID AND ETHYLENE GLYCOL COMONOMERS; MOLDABILITY | KURARAY CO., LTD. (JP) | 1997-11-11 | — | — | US | disclosed |
| EP-0774477-A2 | Copolyesters and molded articles comprising the same | KURARAY CO., LTD. (JP) | 1997-05-21 | — | — | EP | disclosed |
| US-5298652-A | N-substituted glycines, inhibitors of phospholipase A2 | HOFFMANN-LA ROCHE INC. (US) | 1994-03-29 | — | — | US | disclosed |
| JP-S5981192-A | RECORDING MATERIAL | TAOKA CHEM CO LTD | 1984-05-10 | — | — | JP | disclosed |
| US-4138589-A | CHEMICAL INTERMEDIATES FOR COMPOUNDS USED AS X-RAY CONTRAST AGENTS | MALLINCKRODT, INC. (US) | 1979-02-06 | — | — | US | disclosed |
| US-4069250-A | X-RAY CONTRAST AGENTS | MALLINCKRODT, INC. (US) | 1978-01-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250051352-A1 | DIARYLOXYBENZOHETERODIAZOLE COMPOUNDS DISUBSTITUTED WITH THIENOTHIOPHENE GROUPS | SLC9A5, SLC7A5, SLC39A3 | TSHR 400/4885MAPK1 2073/4885HSD17B10 1216/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.